- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 5,55 $ / 5,57 $ |
| Spread | +0,36% |
| Schluss Vortag | 5,57 $ |
| Gehandelte Stücke | 17.779 |
| Tagesvolumen Vortag | 133.857,2 $ |
| Tagestief 5,50 $ Tageshoch 5,59 $ | |
| 52W-Tief 5,375 $ 52W-Hoch 9,08 $ | |
| Jahrestief 5,375 $ Jahreshoch 7,67 $ | |
| Umsatz in Mio. | 348,67 $ |
| Operatives Ergebnis (EBIT) in Mio. | -30,21 $ |
| Jahresüberschuss in Mio. | -22,75 $ |
| Umsatz je Aktie | 12,83 $ |
| Gewinn je Aktie | -0,84 $ |
| Gewinnrendite | -6,52% |
| Umsatzrendite | -6,52% |
| Return on Investment | -7,62% |
| Marktkapitalisierung in Mio. | 145,96 $ |
| KGV (Kurs/Gewinn) | -8,00 |
| KBV (Kurs/Buchwert) | 0,95 |
| KUV (Kurs/Umsatz) | 0,52 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +64,37% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 5,74 $ | 0 % | 5,74 $ | 19.08.26 | |
| Düsseldorf | 4,68 € | -0,43% | 4,70 € | 16:30 | |
| Frankfurt | 4,70 € | 0 % | 4,70 € | 08:03 | |
| Gettex | 4,78 € | 0 % | 4,78 € | 18:43 | |
| L&S RT | 4,78 € | +0,21% | 4,77 € | 19:13 | |
| Nasdaq | 5,56 $ | -0,18% | 5,57 $ | 18:58 | |
| NYSE | 5,57 $ | +0,09% | 5,565 $ | 18:56 | |
| Quotrix | 4,78 € | +0,42% | 4,76 € | 07:27 | |
| Stuttgart | 4,76 € | +0,42% | 4,74 € | 18:47 | |
| Tradegate | 4,86 € | +1,67% | 4,78 € | 24.08.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 26.08.26 | 5,57 | 232 T |
| 25.08.26 | 5,54 | 125 T |
| 24.08.26 | 5,50 | 206 T |
| 21.08.26 | 5,61 | 139 T |
| 20.08.26 | 5,60 | 183 T |
| 19.08.26 | 5,68 | 161 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 5,68 $ | -1,94% |
| 1 Monat | 6,15 $ | -9,43% |
| 6 Monate | 6,46 $ | -13,78% |
| 1 Jahr | 7,99 $ | -30,29% |
| 5 Jahre | 57,98 $ | -90,39% |
| Marktkapitalisierung | 145,96 Mio. $ |
| Streubesitz | 14,36% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Medizinische Instrumente & Zubehör |
| Aktientyp | Stammaktie |
| +6,36% | BlackRock Inc |
| +6,12% | Vanguard Group Inc |
| +3,93% | Acadian Asset Management LLC |
| +3,92% | Kent Lake PR LLC |
| +3,83% | Vanguard Capital Management, LLC |
| +3,61% | Camber Capital Management LLC |
| +3,26% | Ameriprise Financial Inc |
| +3,08% | Dimensional Fund Advisors, Inc. |
| +2,77% | Vanguard MStar Total Stk Mkt Idx Invest |
| +2,73% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,69% | Renaissance Technologies Corp |
| +2,65% | Vanguard Total Stock Mkt Idx Inv |
| +2,51% | Morgan Stanley - Brokerage Accounts |
| +2,46% | Armistice Capital, LLC |
| +2,44% | CS McKee Micro Cap Value |
| +2,39% | Prudential Financial Inc |
| +2,35% | Point72 Asset Management, L.P. |
| +2,28% | Geode Capital Management, LLC |
| +2,24% | Dafna Capital Management LLC |
| +2,14% | Arrowstreet Capital Limited Partnership |
| +2,10% | iShares Russell 2000 ETF |
| +2,09% | Columbia Small Cap Value Discv A |
| +2,03% | Columbia Small Cap Value Discovery Fund |
| +1,93% | Royce & Associates, LP |
| +1,90% | State Street Corp |
| +1,68% | Divisadero Street Capital Management, LP |
| +1,66% | AQR Capital Management LLC |
| +1,61% | Nuveen, LLC |
| +1,58% | The Goldman Sachs Group Inc |
| +1,57% | Federated Hermes Inc |
| +1,47% | JPMorgan Chase & Co |
| +1,38% | Foundry Partners Micro Cap Value |
| +1,37% | Federated Hermes MDT SCC Institutional |
| +1,37% | Federated Hermes MDT Small Cap Core IS |
| +1,34% | CSM Advisors, LLC |
| +1,33% | CREF Total Global Stock Account R3 |
| +1,24% | ExodusPoint Capital Management, LP |
| +1,21% | Royce Micro-Cap Trust |
| +1,15% | Royce Micro Cap Trust |
| +1,13% | Vanguard Institutional Extnd Mkt Idx Tr |
| +1,07% | Jacobs Levy Equity Management, Inc. |
| +1,02% | Connor Clark & Lunn Inv Mgmt Ltd |
| +0,97% | Qube Research & Technologies |
| +0,95% | Peapod Lane Capital LLC |
| +0,89% | Citadel Advisors Llc |
| +0,88% | Fidelity Small Cap Index |
| +0,77% | iShares Russell 2000 Value ETF |
| +0,76% | CREF Stock R3 |
| +0,75% | DFA US Targeted Value I |
| +0,59% | Goldman Sachs Small Cp Val Insghts Instl |
| +0,59% | Dimensional US Targeted Value ETF |
| +0,58% | Russell 2000 Index Non-Lendable Fund |
| +0,57% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,57% | Russell 2000 Equity Index Fund B |
| +0,56% | BSF Systematic US Eq Abs Ret A2 USD |
| +0,54% | Columbia VP Small Cap Value 1 |
| +0,54% | Royce Micro-Cap Invmt |
| +0,53% | Fidelity Extended Market Index |
| +0,49% | JPMorgan US Small Company L |
| +0,46% | Bridgeway Ultra-Small Company |
| +0,44% | Columbia VP Small Cap Value Discovery 1 |
| +0,43% | DFA US Small Cap I |
| +0,42% | Vanguard Russell 2000 ETF |
| +0,42% | Vanguard Strategic Small-Cap Equity Inv |
| +0,41% | PV BUYBACK USA Classe B USD |
| +0,39% | PGIM US SMID Cap Quant Equity |
| +73,481% | Institutionelle Aktionäre |
| +12,157% | Insider Aktionäre |
| +14,362% | Streubesitz |
Zahlen für Q2/20
Mittlerweile auf einem interessanten Bewertungsniveau angekommen.
https://investor.inogen.com/news-events/press-releases/detail/157/inogen-announces-second-quarter-2020-financial-results
Zahlen für Q1/20
" Inogen is withdrawing its previously announced full year 2020 guidance issued on February 25, 2020 as the Company is unable to estimate the scope, duration, and impact of the COVID-19 PHE for full year 2020. The Company believes it could continue to see a decline in sales in its direct-to-consumer channel until patient mobility and consumer confidence increases. The Company also believes the increase in demand that it experienced for its products in the first quarter in its business-to-business channels due to the COVID-19 PHE may be limited or demand may decline in the future as new COPD patient referrals could decline as physician offices are limiting patient interactions. Given the increased uncertainty around the scope, duration, and impact of the COVID-19 PHE as well as revenue mix between direct-to-consumer and business-to-business channels, Inogen cannot estimate the overall impact to its operations and financial results, which could be material. Due to these uncertainties, the Company is implementing cost savings by delaying certain personnel hires and reducing advertising spend, while also increasing rental setups to improve lead utilization."
https://investor.inogen.com/news-events/press-releases/detail/153/inogen-announces-first-quarter-2020-financial-results
